Indefinite Delivery Contract SPE2DB24D9213

Award Date 3/11/24
Last Date to Order 12/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at $499,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued up to $499,999,999, covers the period from October 2, 2024 through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military health facilities worldwide....
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at $499,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) under its Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at up to $499,999,999, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract encompasses the...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at $499,999,999, is valid through November 2026 and enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC covers an extensive portfolio of...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC has a period of performance through November 2026 and enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contracted products include branded and generic...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Illinois. The single-award contract, valued up to $499,999,999, runs through December 31, 2025 and is part of the DLA's SPE2DB program. Under this IDC, DMS Pharmaceutical Group will provide a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities supported by DLA...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $499,999,999 single-award IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group supplies...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at $499,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including...
  • SPE2DB24D9213
    Indefinite Delivery Contract
  • 23
    Federal Contract Awards

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The single-award IDC, valued up to $499,999,999, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to support the medical supply needs of military health facilities worldwide.

Key items included under this IDC span multiple therapeutic categories, such as naltrexone tablets, botulinum toxin injections, contraceptive implants, chemotherapy drugs, HIV antiretrovirals, ophthalmic solutions, injectable anesthetics, and other branded and generic medications. The contract, which runs through December 2025, complements DMS Pharmaceutical Group's existing prime vendor contracts for direct pharmaceutical distribution and pharmacy services to Department of Defense sites. This IDC allows DLA to efficiently procure recurring pharmaceutical supplies required by military medical facilities globally.

Generated 6/10/24, 9:04 AM